Meilinkangda pharmaceutical is a national high-tech enterprise integrating scientific research, production, sales of drugs and medical devices and modern biomedical logistics. The first phase covers an area of 25 mu, with a total construction area of 12122.02 ㎡ and a construction investment of 125 million yuan. It is mainly for the production of Chinese herbal pieces, intelligent medicine logistics and scientific research center area. In 2020, at present, Jiangxi meilinkang Pharmaceutical Co., Ltd. actively performs its social responsibility and takes on its responsibilities. It invested in the construction of disposable medical mask and N95 mask production line to realize disposable medical mask and N95 production of masks. Mask production workshops of meilinkangda Pharmaceutical Co., Ltd. are all 100000 level purification workshops, with a total purification area of 3800 square meters.
The company operates well, with revenue (including third-party logistics business) of 63 million yuan and profit of 7.24 million yuan in 2017. In 2018, the revenue (including the third-party logistics business) was 65.86 million yuan, and the profit was 8.84 million yuan. In 2019, the revenue (including the third-party logistics business) will be 89.9 million yuan, and the profit will be 14.08 million yuan.
The company has already obtained the drug production license, GMP, food business license, drug operation permit, GSP and medical device business license (three categories). The company has established the "Meilin big health business platform" and "Internet plus, intelligent medicine and medicine logistics platform". The drug business will cover all hospitals in Jingdezhen, make up for the shortage of drug distribution in Jingdezhen, establish a national drug sales network, and integrate online and offline operations. The company is equipped with an information-based and intelligent pharmaceutical logistics management system, which has been built into the largest pharmaceutical logistics storage center in Northeast Jiangxi, with electronic label storage management and information-based pharmaceutical logistics distribution, with an annual distribution scale of 3 billion yuan.